Tianjin Pharmaceutical Da Ren Tang Overview
- Status
-
Public
- Employees
-
3,835
- Stock Symbol
-
600329
- Investments
-
3
- Share Price
-
$4.88
- (As of Tuesday Closing)
Tianjin Pharmaceutical Da Ren Tang General Information
Description
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Contact Information
Website
www.jydrt.com.cnCorporate Office
- Zhong Xin Mansion
- 17 Baidi Road Nankai District
- Tianjin, 300193
- China
Corporate Office
- Zhong Xin Mansion
- 17 Baidi Road Nankai District
- Tianjin, 300193
- China
Tianjin Pharmaceutical Da Ren Tang Stock Performance
As of 15-Jul-2025, Tianjin Pharmaceutical Da Ren Tang’s stock price is $4.88. Its current market cap is $3.28B with 770M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.88 | $4.62 | $3.68 - $5.56 | $3.28B | 770M | 5.16M | $0.40 |
Tianjin Pharmaceutical Da Ren Tang Financials Summary
As of 31-Mar-2025, Tianjin Pharmaceutical Da Ren Tang has a trailing 12-month revenue of $927M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 2,465,621 | 2,815,861 | 2,948,662 | 2,331,679 |
| Revenue | 926,620 | 1,018,295 | 1,162,184 | 1,224,917 |
| EBITDA | 358,869 | 378,532 | 170,562 | 156,045 |
| Net Income | 307,593 | 310,689 | 139,466 | 127,966 |
| Total Assets | 1,537,469 | 1,475,134 | 1,443,177 | 1,472,176 |
| Total Debt | 10,859 | 3,916 | 46,433 | 37,382 |
Tianjin Pharmaceutical Da Ren Tang Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tianjin Pharmaceutical Da Ren Tang Investments & Acquisitions (3)
Tianjin Pharmaceutical Da Ren Tang’s most recent deal was a Secondary Transaction - Private with Shike Pharma. The deal was made on 23-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shike Pharma | 23-Nov-2022 | Secondary Transaction - Private | Pharmaceuticals | ||
| Jing Wanhong | 19-Sep-2022 | Merger/Acquisition | Medical Supplies | ||
| Shike Pharma | 23-Sep-1984 | Joint Venture | Pharmaceuticals |
Tianjin Pharmaceutical Da Ren Tang ESG
Risk Overview
Risk Rating
Updated January, 18, 2025
35.88 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 420
Rank
Percentile
Tianjin Pharmaceutical Da Ren Tang Exits (2)
Tianjin Pharmaceutical Da Ren Tang’s most recent exit was on 23-Nov-2022 from Shike Pharma. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Shike Pharma | 23-Nov-2022 | Completed |
|
||
| Shike Pharma | 23-Sep-1984 | Joint Venture | Completed |
|
Tianjin Pharmaceutical Da Ren Tang Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Jing Wanhong | Tianjin, China | 1981 |
Tianjin Pharmaceutical Da Ren Tang FAQs
-
Where is Tianjin Pharmaceutical Da Ren Tang headquartered?
Tianjin Pharmaceutical Da Ren Tang is headquartered in Tianjin, China.
-
What is the size of Tianjin Pharmaceutical Da Ren Tang?
Tianjin Pharmaceutical Da Ren Tang has 3,835 total employees.
-
What industry is Tianjin Pharmaceutical Da Ren Tang in?
Tianjin Pharmaceutical Da Ren Tang’s primary industry is Pharmaceuticals.
-
Is Tianjin Pharmaceutical Da Ren Tang a private or public company?
Tianjin Pharmaceutical Da Ren Tang is a Public company.
-
What is Tianjin Pharmaceutical Da Ren Tang’s stock symbol?
The ticker symbol for Tianjin Pharmaceutical Da Ren Tang is 600329.
-
What is the current stock price of Tianjin Pharmaceutical Da Ren Tang?
As of 15-Jul-2025 the stock price of Tianjin Pharmaceutical Da Ren Tang is $4.88.
-
What is the current market cap of Tianjin Pharmaceutical Da Ren Tang?
The current market capitalization of Tianjin Pharmaceutical Da Ren Tang is $3.28B.
-
What is Tianjin Pharmaceutical Da Ren Tang’s current revenue?
The trailing twelve month revenue for Tianjin Pharmaceutical Da Ren Tang is $927M.
-
What is Tianjin Pharmaceutical Da Ren Tang’s annual earnings per share (EPS)?
Tianjin Pharmaceutical Da Ren Tang’s EPS for 12 months was $0.40.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
